Gregory Gullo
Interventional Pain Medicine · West Linn, ORNPI 1124075791
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,185 of the $4,494 with a category attached, or 70.9%. 28 manufacturers reported payments, led by Abbott at 26.9% of the total. Reporting peaked in 2020 at $2,044 and has fallen 99.3% since, to $15 in 2023. That places this record below the midpoint for interventional pain medicine clinicians in OR, where the typical reported total is $8,094.
Across 163 payments — averaging $27.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- VGI Medical, LLC$445
- Pfizer$293
- Daiichi Sankyo Inc.$290
- AbbVie$289
- Nevro Corp.$255
- plus $2K from 22 others
What the payments were for
- Travel & lodging$86419%
- Food & beverage$3,18571%
- Entertainment$44510%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $1,207 |
| VGI Medical, LLC | 1 | $445 |
| Pfizer | 20 | $293 |
| Daiichi Sankyo Inc. | 30 | $290 |
| AbbVie(2 entities) | 15 | $289 |
| Nevro Corp. | 3 | $255 |
| Lilly USA, LLC | 11 | $254 |
| Biodelivery Sciences International, Inc. | 8 | $180 |
| GRT US Holding, Inc. | 2 | $135 |
| Medtronic | 3 | $130 |
| Amgen | 6 | $121 |
| Stimwave Technologies Incorporated | 3 | $109 |
| Biohaven Pharmaceuticals, Inc. | 5 | $97 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| Scilex Pharmaceuticals Inc. | 5 | $89 |
| Boston Scientific | 1 | $77 |
| Zyla Life Sciences, Inc. | 5 | $69 |
| Arbor Pharmaceuticals, Inc. | 4 | $53 |
| MDD US Operations, LLC | 3 | $53 |
| Pacira Therapeutics, Inc. | 3 | $47 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $34 |
| Tersera Therapeutics LLC | 3 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Si-bone, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Assertio Therapeutics, Inc. | 1 | $19 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,494 in reported general payments places this provider in the 45th percentile of 22 interventional pain medicine providers in Oregon.
Other interventional pain medicine in West Linn
- Gregory MooreEugene$377K
- Gregory PhillipsEugene$50K
- Stephen PeirceEugene$28K
- Rishi VoraEugene$16K
- George JohnstonMedford$14K
- Poly ChenSalem$14K
- Kwo Wei HoTigard$13K
- Carl BalogPortland$12K
- Joseph DunnEugene$10K
- Donna MorganEugene$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.